CERC-006
CERC-006-LM-101
Phase 1 small_molecule terminated
Quick answer
CERC-006 for Lymphatic Malformation is a Phase 1 program (small_molecule) at Avalo Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Avalo Therapeutics
- Indication
- Lymphatic Malformation
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated